Zoetis Inc. Files Q3 2024 10-Q Report
Ticker: ZTS · Form: 10-Q · Filed: 2024-11-04T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Zoetis Q3 2024 10-Q filed. Financials look solid.
AI Summary
Zoetis Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the year. Key financial data and operational details for this period are presented, reflecting the company's performance in the animal health sector.
Why It Matters
This report provides investors with a detailed look at Zoetis' financial health and operational performance for the third quarter of 2024, crucial for understanding the company's trajectory in the animal health market.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- Zoetis Inc. (company) — Filer of the 10-Q report
- 2024-09-30 (date) — End of the reporting period
- 2024-11-04 (date) — Filing date of the report
FAQ
What is the reporting period for this 10-Q filing?
The 10-Q filing is for the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 4, 2024.
What is Zoetis Inc.'s Standard Industrial Classification code?
Zoetis Inc.'s SIC code is 2834, for Pharmaceutical Preparations.
What is the company's primary business address?
Zoetis Inc.'s business address is 10 Sylvan Way, Parsippany, NJ 07054.
What fiscal year end does Zoetis Inc. report?
Zoetis Inc. reports its fiscal year end as December 31.
From the Filing
0001555280-24-000332.txt : 20241104 0001555280-24-000332.hdr.sgml : 20241104 20241104135213 ACCESSION NUMBER: 0001555280-24-000332 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 96 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241104 DATE AS OF CHANGE: 20241104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 241422419 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 10-Q 1 zts-20240930.htm 10-Q zts-20240930 false 2024 Q3 0001555280 12/31 383 365 308 xbrli:shares iso4217:USD iso4217:USD xbrli:shares zts:geographicRegion zts:country zts:specie zts:productCategory zts:product_category xbrli:pure iso4217:EUR iso4217:DKK iso4217:CHF zts:defendant zts:segment 0001555280 2024-01-01 2024-09-30 0001555280 2024-10-31 0001555280 2024-07-01 2024-09-30 0001555280 2023-07-01 2023-09-30 0001555280 2023-01-01 2023-09-30 0001555280 us-gaap:CashFlowHedgingMember 2024-07-01 2024-09-30 0001555280 us-gaap:CashFlowHedgingMember 2023-07-01 2023-09-30 0001555280 us-gaap:CashFlowHedgingMember 2024-01-01 2024-09-30 0001555280 us-gaap:CashFlowHedgingMember 2023-01-01 2023-09-30 0001555280 us-gaap:NetInvestmentHedgingMember 2024-07-01 2024-09-30 0001555280 us-gaap:NetInvestmentHedgingMember 2023-07-01 2023-09-30 0001555280 us-gaap:NetInvestmentHedgingMember 2024-01-01 2024-09-30 0001555280 us-gaap:NetInvestmentHedgingMember 2023-01-01 2023-09-30 0001555280 2024-09-30 0001555280 2023-12-31 0001555280 us-gaap:CommonStockMember 2024-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2024-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001555280 us-gaap:RetainedEarningsMember 2024-06-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001555280 us-gaap:NoncontrollingInterestMember 2024-06-30 0001555280 2024-06-30 0001555280 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001555280 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001555280 us-gaap:TreasuryStockCommonMember zts:ShareRepurchaseProgramMember 2024-07-01 2024-09-30 0001555280 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001555280 us-gaap:CommonStockMember 2024-09-30 0001555280 us-gaap:TreasuryStockCommonMember 2024-09-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001555280 us-gaap:RetainedEarningsMember 2024-09-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001555280 us-gaap:NoncontrollingInterestMember 2024-09-30 0001555280 us-gaap:CommonStockMember 2023-06-30 0001555280 us-gaap:TreasuryStockCommonMember 2023-06-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001555280 us-gaap:RetainedEarningsMember 2023-06-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001555280 us-gaap:NoncontrollingInterestMember 2023-06-30 0001555280 2023-06-30 0001555280 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001555280 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001555280 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001555280 us-gaap:TreasuryStockCommonMember zts:ShareRepurchaseProgramMember 2023-07-01 2023-09-30 0001555280 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001555280 us-gaap:CommonStockMember 2023-09-30 0001555280 us-gaap:TreasuryStockCommonMember 2023-09-30 0001555280 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001555280 us-gaap:R